Canal Insurance Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,000
Closed -$536K 73
2025
Q2
$536K Hold
60,000
0.12% 66
2025
Q1
$523K Hold
60,000
0.12% 70
2024
Q4
$747K Hold
60,000
0.19% 61
2024
Q3
$697K Hold
60,000
0.16% 70
2024
Q2
$638K Hold
60,000
0.17% 66
2024
Q1
$716K Hold
60,000
0.18% 66
2023
Q4
$650K Hold
60,000
0.18% 64
2023
Q3
$592K Hold
60,000
0.17% 64
2023
Q2
$594K Hold
60,000
0.17% 69
2023
Q1
$580K Hold
60,000
0.16% 70
2022
Q4
$668K Buy
60,000
+40,868
+214% +$427K 0.18% 67
2022
Q3
$163K Hold
19,132
0.05% 86
2022
Q2
$203K Hold
19,132
0.06% 79
2022
Q1
$210K Hold
19,132
0.06% 78
2021
Q4
$259K Hold
19,132
0.08% 75
2021
Q3
$262K Hold
19,132
0.09% 65
2021
Q2
$275K Hold
19,132
0.1% 63
2021
Q1
$270K Hold
19,132
0.1% 51
2020
Q4
$359K Buy
+19,132
New +$312K 0.15% 54

Other funds holding VTRS

Canal Insurance Company's VTRS Position: Q3 2025 in Review

Canal Insurance Company sold out of Viatris (VTRS) in Q3 2025, closing a stake of 60,000 shares — an estimated $536K sold.

Canal Insurance Company first reported a position in VTRS in Q4 2020 and held it in 19 quarters. The position peaked at $747K in Q4 2024. 968 funds tracked by Wall St. Rank hold VTRS as of Q3 2025.

  • Canal Insurance Company reported no remaining Viatris position as of Q3 2025 after selling out during the quarter.
  • Canal Insurance Company sold 60,000 Viatris shares in Q3 2025, an estimated $536K.
  • Canal Insurance Company first reported a position in Viatris in Q4 2020 and held it in 19 quarters.
  • Canal Insurance Company's Viatris position peaked at $747K in Q4 2024.
  • 968 funds tracked by Wall St. Rank held Viatris as of Q3 2025.

Based on Canal Insurance Company's 13F filing for Q3 2025, filed 27 Oct 2025.